# Daniel A. Pontecorvo

> Daniel A. Pontecorvo is a Pennsylvania company founder and executive associated with VYRSA Technologies and Camber Spine. His career spans device distribution, company leadership, investment and board work. He co-founded Camber in 2010, served as CEO until October 2023 and became Executive Chairman. VYRSA, established in 2021, was acquired by Nevro in November 2023 for $40 million upfront and up to $35 million in contingent payments.

- **Role:** Founding Partner and Executive Chairman of the Board at Camber Spine
- **Organizations:** Camber Spine, VYRSA Technologies, L5 Surgical, Synthes, Puratec, Institute for Musculoskeletal Science and Education
- **Known for:** Led the L5 Surgical distribution team that generated upwards of $35 million in annual sales within five years, according to Camber’s biography., Co-founded Camber Spine in 2010., EY Entrepreneur Of The Year 2020 Greater Philadelphia Award finalist.

## Career timeline

- **2005** — L5 Surgical, formed by Pontecorvo and Bob Antonelli, was publicly announced as a Globus Medical independent distributor.
- **2010** — Co-founded Camber Spine and an education institute.
- **2018** — Trade coverage identified him as CEO and founding investor of Puratec.
- **2019** — As CEO, announced Camber’s move to a 27,000-square-foot King of Prussia headquarters.
- **2020** — Named an EY Entrepreneur Of The Year Greater Philadelphia Award finalist.
- **2022** — Identified as VYRSA CEO in its announcement of Earl Fender’s board appointment.
- **2023-10** — Concluded his tenure as Camber CEO and became Executive Chairman.
- **2023-11** — Signed VYRSA’s acquisition agreement as Co-Chief Executive Officer; Nevro acquired the company on November 30.

## Achievements

- Led the L5 Surgical distribution team that generated upwards of $35 million in annual sales within five years, according to Camber’s biography.
- Co-founded Camber Spine in 2010.
- EY Entrepreneur Of The Year 2020 Greater Philadelphia Award finalist.
- Helped lead VYRSA before its acquisition by Nevro for $40 million at closing and up to $35 million in milestone consideration.

## Latest updates

- **2025-04** — Globus Medical completed its acquisition of Nevro, which had acquired VYRSA in 2023.

## Links

- LinkedIn: https://www.linkedin.com/in/daniel-a-pontecorvo-b6173a16

---

Profile page: https://yespress.io/daniel-a-pontecorvo
Published by YesPress — https://yespress.io
Last updated: 2026-10-16